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Stimulant Induced Chorea
Carrie Schmitt, DO MS, Imran Tarrar, MD & Alicja Wasilewski, MD
Psychiatry Residency, Henry Ford Allegiance Health

Introduction

Case Report

Discussion

Adderall, a Dextroamphetamine/Levoamphetamine salt, a synthetic
compound similar to methamphetamines, is a widely used stimulant type
medication commonly used to treat Attention Deficit Hyperactivity
Disorder and Attention Deficit Disorder in children, adolescents, and adults.
It works through a mechanism of increasing the release of both
norepinephrine and dopamine in the central nervous system, thereby
enhancing cognitive effects of increased wakefulness, improved cognitions
of focus and concentration, and decreasing hyperactivity, impulsivity and
inattentiveness. But at higher doses or through methods of abuse Adderall
can cause signs of impaired cognitive function, signs of psychosis, and
produce movement disorders, such as chorea.

A 39 year old female with a past psychiatric history of mood disorder,
anxiety, and attention deficit disorder was initially admitted to the
hospital ICU unresponsive status post-cardiac arrest of unknown origin.
While in the ICU and intubated, the patient had an additional episode of
ventricular tachycardia and subsequent cardiac arrest, necessitating
defibrillation and shock.
Days after admission:
− Day 1: Cardiology consultation for evaluation of causation of
cardiac arrest. Likely etiology peripartum cardiomyopathy. The
patient, G15P10, recently delivered her 10th child less than 1 month
prior to admission.
− Day 3: Neurology consultation for concerns of unresponsiveness.
Patient starting to regain consciousness, still intubated, but
requiring chemical and physical restraints due to agitation.
Assessment of encephalopathy and recommended MRI brain.
− Day 5: Psychiatry consultation for assessment and management of
mood disorder. On MSE, patient presented pleasant, cooperative, no
use of restraints noted, and did not show any signs of mood
alteration, depression, or anxiety. Most prominent feature on MSE
was cognitive impairment with difficulties in attention,
concentration, registration, and short-term memory. Cause of
cognitive impairment speculated as related to anoxia from recent
cardia arrest. History of “street drug” use elicited by family; patient
denied.
− Day 9: Psychiatry re-consultation for behavior of severe agitation,
aggression towards hospital staff, requiring the use of physical
restraints after being transferred from the ICU to the medical floor.
On MSE, patient was AOx1, very disorganized, hyperverbal, loud,
agitated, and displaying prominent choreoathetotic movements of :
involuntary jerking surrounding the face, shoulders, and pelvis.
Patient necessitated assistance when walking due to the movements
and instability. Patient’s home medications of Celexa 20 mg daily,
Adderall 30 mg twice daily, and Ativan 1 mg daily. Patient denied
any history of drug abuse, but did admit to possibly taking more
than prescribed after recent birth of her 10th child (22 days prior).

It is well known that at high doses or through forms of misuse and
abuse that stimulants can cause movement disorders, such as chorea.
But there is additional research supporting evidence that at lower doses
or commonly prescribed doses over an extended long period of time
that stimulants can cause changes in cell processes and surface
structure in the brain, most notably in the nigrostriatal pathway of the
dorsal striatum and substantia nigra, leading to a possible dosedependent relationship to some of the adverse effects seen with
stimulants as is such a possibility in this case.

Figure 1: Chemical Structures of Amphetamine and Methamphetamine

Chorea is characterized by abnormal involuntary movements that can
consist of short, irregular, asymmetrical, sudden, unexpected, nonstereotypy movements.

Labs

Upon regaining consciousness, this patient demonstrated movements
of: involuntary, abrupt, random, repetitive, non-stereotypied, jerking,
which are consistent with choreathetosis. After discussion with the
patient and obtaining collateral information with family members and
the Michigan MAPS system, it was concluded that the patient’s
movements were due a combination of prolonged Adderall use through
prescription and the recent self-increase in the amount of Adderall.
Patient believed the increase would help with fatigue and low energy
after the birth of her 10th child. This unprecedented increase of the
stimulant lead to the development of acute chorea, which resolved
within days after no stimulant use.
Treatment: In this case, treatment included stopping the suspected
offending agent, which was Adderall. Providing supportive care as
needed, including benzodiazepines for agitation. We recommended
avoiding the use of antipsychotic medications altogether due to the
potential cardiac complications as the patient was status-post 2 cardiac
arrests and diagnosed with a peripartum cardiomyopathy.

Conclusion
This case illustrates the importance of considering prolonged prescribed
stimulant use in the context of misuse as a development of chorea.

Figure 2: Image of Chorea

Chorea can have various causes including:
• Hereditary diseases (Huntington’s, Wilsons, Lesch Nyhan,
Friedreich’s Ataxia),
• Post-infectious syndromes (Sydenham’s chorea),
• Medical (thyrotoxicosis, HIV, cerebrovascular),
• Immune-mediated (SLE, Celiac),
• Endocrine and metabolic (pregnancy, polycythemia vera),
• Drug-induced (levodopa, neuroleptics, anti-convulsants, oral
contraceptive pills),
• Misuse of psychostimulants (cocaine, methamphetamine,
amphetamine)

CMP: AST/ALT (47/17), Alk Phos (148)
CBC: WBC (21.9), H/H (10.5/33.7), Platelets (454), Neutrophils (19.27)
TSH (1.59), Troponin (0.02), Lactate (6.6), Procalcitonin (1.36), UA (-)
UDS: (+) amphetamine, (-) benzodiazepine, (-) EtOH
MAPS: Adderall script filled 4 days prior to hospital admission
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Imaging
CT Head: (-)
EKG: sinus rhythm with occasional PVCs and LAD
ECHO: EF 35%, global hypokinesis with LV dilation
24 hour EEG: moderate diffuse encephalopathy, (-) epileptiform activity
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